KSI vs. VHI, CARE, RHT, ADK, DOC, EKG, ZMD, CNNA, CARE.TO, and UDOC
Should you be buying kneat.com stock or one of its competitors? The main competitors of kneat.com include Vitalhub (VHI), Dialogue Health Technologies (CARE), Reliq Health Technologies (RHT), DIAGNOS (ADK), CloudMD Software & Services (DOC), CardioComm Solutions (EKG), ZoomMed (ZMD), Cann American (CNNA), Dialogue Health Technologies (CARE.TO), and Unidoc Health (UDOC). These companies are all part of the "health information services" industry.
kneat.com vs. Its Competitors
Vitalhub (TSE:VHI) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.
Vitalhub has a net margin of 5.11% compared to kneat.com's net margin of -17.59%. Vitalhub's return on equity of 3.01% beat kneat.com's return on equity.
In the previous week, Vitalhub had 4 more articles in the media than kneat.com. MarketBeat recorded 6 mentions for Vitalhub and 2 mentions for kneat.com. kneat.com's average media sentiment score of 1.35 beat Vitalhub's score of 0.73 indicating that kneat.com is being referred to more favorably in the news media.
Vitalhub has higher revenue and earnings than kneat.com. Vitalhub is trading at a lower price-to-earnings ratio than kneat.com, indicating that it is currently the more affordable of the two stocks.
Vitalhub has a beta of 0.615379, meaning that its stock price is 38% less volatile than the S&P 500. Comparatively, kneat.com has a beta of 1.195517, meaning that its stock price is 20% more volatile than the S&P 500.
24.9% of Vitalhub shares are held by institutional investors. Comparatively, 3.9% of kneat.com shares are held by institutional investors. 18.6% of Vitalhub shares are held by company insiders. Comparatively, 26.0% of kneat.com shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Vitalhub currently has a consensus price target of C$14.86, indicating a potential upside of 38.85%. kneat.com has a consensus price target of C$6.50, indicating a potential upside of 12.07%. Given Vitalhub's higher possible upside, research analysts clearly believe Vitalhub is more favorable than kneat.com.
Summary
Vitalhub beats kneat.com on 11 of the 17 factors compared between the two stocks.
Get kneat.com News Delivered to You Automatically
Sign up to receive the latest news and ratings for KSI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding KSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
kneat.com Competitors List
Related Companies and Tools
This page (TSE:KSI) was last updated on 10/16/2025 by MarketBeat.com Staff
